TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First ...
Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...
No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...
A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...
RFdiffusion2, RFdiffusion3, and Riff-Diff each solve different structural problems in computational enzyme design ...
Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...
Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems, has announced the publication of a new study in Nature Biomedical Engineering, titled "Spatial profiling of gene editing by ...
AGC Biologics is partnering with ATUM to integrate technology designed to increase yields and shorten the path to clinical trials.
A new review in Chinese Medical Journal details progress in nanocarrier-based cancer therapy. It analyzes polymeric, lipidic, ...
A region of DNA that codes for a protein, often referred to as a gene, is the fundamental unit of heredity responsible for specific traits and functions within an organism. This intricate segment of ...
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback